2型糖尿病 (T2D) 患者的隐性饥饿及其对血糖控制的影响:系统审查和元分析的方案
Daya Krishan Mangal1, Diksha Gautam2, Anuj Kumar Pandey2
1IIHMR University, Jaipur, India mangaldk@iihmr.org.
BMJ open
|March 26, 2024
概括
隐藏的饥饿或微量营养素缺乏在全球范围内很常见,可能会使2型糖尿病 (T2D) 的结果恶化. 本综述评估了缺陷患病率及其对T2D患者血糖控制的影响.
科学领域:
- 营养科学 营养科学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 微量营养素缺乏,称为"隐性饥饿",在全球范围内普遍存在,特别是在南亚和撒哈拉以南非洲.
- 这些缺陷可能会影响胰岛素信号传递和葡萄糖代谢,可能导致2型糖尿病 (T2D) 的发展和进展.
研究的目的:
- 估计T2D患者多种微量营养素缺乏的患病率.
- 评估这些缺陷对T2D患者血糖控制的影响.
主要方法:
- 一个系统的审查,遵守柯克兰手册和PRISMA 2020指南.
- 在PubMed,Scopus,EMBASE,LILACS,ProQuest,Google Scholar和灰色文学中进行全面的文献搜索.
- 使用试点表提取数据;通过JBI Sumari和R软件进行分析,包括流行率和血糖控制结果的元分析.
主要成果:
- 将估计T2D患者中各种微量营养素缺乏的综合患病率.
- 几率比率和风险比率将量化缺陷对血糖控制的影响.
结论:
- 结果将突出显示微量营养素状况与T2D中的血糖控制之间的联系.
- 结果可以告知有针对性的干预措施,通过解决营养缺陷来改善糖尿病管理.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes: Symptoms, Diagnosis, and Complications
530
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
530
Insulin: Dosing Regimen and Adverse Effects
169
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
169


